Wednesday, May 11, 2016

Express Scripts Looks To Deep-Six Pharmacy Antitrust Claims By John Kennedy

Express Scripts Looks To Deep-Six Pharmacy Antitrust Claims

Law360, New York (May 10, 2016, 9:46 PM ET) -- A number of compounding pharmacies accusing Express Scripts of conspiring with other pharmacy benefit managers to put them out of business by strangling the market for compounded drugs haven't provided enough evidence to back up their claims, Express told a Missouri federal court Monday.

Express countered Precision RX Compounding LLC’s April assertion that the pharmacy benefit manager's dismissal motion was nothing more than “self-serving fiction,” with its own pointed attack on Precision’s allegedly imprecise allegations that Express increased rejection rates for compounded medicines, created "significant obstacles" to...
To view the full article, register now.

No comments: